Unknown

Dataset Information

0

An integrated multigene expression panel to predict long-term survival after curative hepatectomy in patients with hepatocellular carcinoma.


ABSTRACT: Hepatocellular carcinoma (HCC) frequently recurs even after curative hepatectomy. To develop an integrated multigene expression panel, 144 patients were randomly assigned to either discovery or validation set in a 1:2 ratio. Using surgically resected HCC specimens, expression levels of 12 candidate molecular markers were determined using quantitative reverse-transcriptase PCR. In the discovery set, an expression panel was developed according to the concordance index (C-index) values for overall survival from all 4095 combinations of the 12 candidate molecular markers. Expression scores was determined with weighting according to the coefficient in a Cox regression, and patients were classified into grade 1, 2 and 3. Reproducibility was then tested in the validation set. A panel consisting of four markers, PRMT5, MAGED4, DPYSL3 and AJAP1 was selected as the optimal and most well-balanced set with a C-index value of 0.707. Patient prognosis was clearly stratified by the expression grade using this panel. In the validation set, both overall and disease-free survival rates decreased incrementally with as the grade increased. Higher grades were significantly associated with tumor multiplicity and vessel invasion. The prevalence of extrahepatic recurrences was increased in grade 3 patients. The integrated multigene expression panel clearly stratified HCC patients into low, intermediate and high risk.

SUBMITTER: Kanda M 

PROVIDER: S-EPMC5642618 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

An integrated multigene expression panel to predict long-term survival after curative hepatectomy in patients with hepatocellular carcinoma.

Kanda Mitsuro M   Murotani Kenta K   Sugimoto Hiroyuki H   Miwa Takashi T   Umeda Shinichi S   Suenaga Masaya M   Hayashi Masamichi M   Hattori Norifumi N   Tanaka Chie C   Kobayashi Daisuke D   Yamada Suguru S   Fujiwara Michitaka M   Kodera Yasuhiro Y  

Oncotarget 20170819 41


Hepatocellular carcinoma (HCC) frequently recurs even after curative hepatectomy. To develop an integrated multigene expression panel, 144 patients were randomly assigned to either discovery or validation set in a 1:2 ratio. Using surgically resected HCC specimens, expression levels of 12 candidate molecular markers were determined using quantitative reverse-transcriptase PCR. In the discovery set, an expression panel was developed according to the concordance index (C-index) values for overall  ...[more]

Similar Datasets

| S-EPMC7977285 | biostudies-literature
| S-EPMC8487667 | biostudies-literature
| S-EPMC7641545 | biostudies-literature
| S-EPMC4509272 | biostudies-literature
| S-EPMC4621918 | biostudies-literature
| S-EPMC8217564 | biostudies-literature
| S-EPMC8027067 | biostudies-literature
| S-EPMC9291378 | biostudies-literature
| S-EPMC5922354 | biostudies-literature
| S-EPMC4428764 | biostudies-literature